Obstetrics & gynaecology

Studies of menopausal hormone therapy reviewed

Treatment with estrogen in menopause is both good and bad for women's health. The picture is complex and the scientific evidence sometimes scanty or only moderately solid, a study shows. University of Gothenburg researchers ...

Overweight & Obesity

Diabetes drug's new weight loss formula fuels cost-benefit debate

The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people—especially ...

Cardiology

Early rhythm control key in A-fib and heart failure

(HealthDay)—For patients with atrial fibrillation and signs and symptoms of heart failure, early rhythm control (ERC) therapy reduces cardiovascular events, according to a study published online July 30 in Circulation to ...

Medications

FDA defends approval of controversial Alzheimer's drug

The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science.

Diseases, Conditions, Syndromes

WHO says not to use ivermectin on COVID-19 patients

The World Health Organization said Wednesday that ivermectin—touted by some on social media as a COVID-19 "miracle cure"—should not be used to treat coronavirus patients.

page 9 from 24